News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,003 Results
Type
Article (88166)
Company Profile (825)
Press Release (783992)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18431)
Job Trends (17439)
News (398112)
Policy (39994)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (40)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (373)
Approvals (18628)
Artificial intelligence (676)
Autoimmune disease (189)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (172)
Brain cancer (68)
Breast cancer (693)
Cancer (5303)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (67)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77356)
Collaboration (1938)
Company closure (5)
Compensation (1222)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (956)
Cystic fibrosis (155)
Data (6624)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7315)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (257)
Earnings (100695)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135753)
Executive appointments (1068)
FDA (21782)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1630)
Gene editing (230)
Generative AI (71)
Gene therapy (711)
GLP-1 (1164)
Government (5479)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (75)
Indications (128)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (395)
Machine learning (48)
Management (66)
Manufacturing (916)
MASH (182)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23032)
Metabolic disorders (1470)
mRNA (201)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3235)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (717)
Opinion (347)
Ovarian cancer (173)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (316)
Partnered (39)
Patents (544)
Patient recruitment (545)
Peanut (64)
People (67131)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23904)
Phase 2 (33567)
Phase 3 (25285)
Pipeline (5955)
Policy (357)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (270)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (997)
Real estate (7444)
Recruiting (81)
Regulatory (29317)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1190)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (2)
Last 7 days (935)
Last 30 days (2878)
Last 365 days (32636)
2026 (5316)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51676)
Australia (9081)
California (12136)
Canada (3457)
China (1223)
Colorado (512)
Connecticut (526)
Delaware (361)
Europe (118890)
Florida (1801)
Georgia (393)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (79)
Indiana (572)
Iowa (24)
Japan (461)
Kansas (135)
Kentucky (47)
Louisiana (31)
Maine (84)
Maryland (1509)
Massachusetts (8890)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3254)
New Mexico (33)
New York (3199)
North Carolina (1673)
North Dakota (10)
Northern California (5867)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2416)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4698)
Tennessee (185)
Texas (1908)
United States (43643)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,003 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 1, 2026
·
15 min read
Press Releases
Nkarta to Participate in March 2026 Investor Conferences
March 1, 2026
·
1 min read
Press Releases
Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering
February 27, 2026
·
5 min read
Press Releases
Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement
February 27, 2026
·
5 min read
Press Releases
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million
February 27, 2026
·
6 min read
Press Releases
CNIO Awarded Three-Year Grant to Advance MeCo Score in Breast Cancer
€320K grant awarded to internationally ranked top-10 cancer institute supports expansion of MeCo Diagnostics’ predictive biomarker guiding antifibrotic therapy
February 27, 2026
·
1 min read
Press Releases
Restart Life Sciences Closes Acquisition of Holy Crap Foods
February 27, 2026
·
8 min read
Vaccines
Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule
The CDC’s changes threaten to cut vaccine sales for makers including Pfizer, Moderna, Merck and more, but a legal expert suspects affected manufacturers will stay on the sidelines rather than back a push to declare the revised schedule unlawful.
February 27, 2026
·
2 min read
·
Nick Paul Taylor
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite these treatments.
February 27, 2026
·
6 min read
·
Heather McKenzie
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
FDA Commissioner Marty Makary presented a new idea to staff this week: bonus payments for employees that complete regulatory review processes faster than expected.
February 27, 2026
·
1 min read
·
Annalee Armstrong
1 of 87,301
Next
